Eurofins Calixar Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
Eurofins Calixar General Information
Description
Operator of a biotechnology company intended to preserve the original structure and function of membrane protein operations. The company engages in the production, extraction, stabilization, purification, and crystallization of functional membrane proteins and antigens, by isolating them in a native conformation without mutations or deletions, enabling biotechnology companies to develop conformational antibodies and formulate new vaccines efficiently.
Contact Information
Website
www.calixar.com(Operating Subsidiary)
Corporate Office
- Bâtiment Laennec
- 60A Avenue Rockefeller
- 69008 Lyon
- France
Corporate Office
- Bâtiment Laennec
- 60A Avenue Rockefeller
- 69008 Lyon
- France
Eurofins Calixar Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 23-Apr-2023 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Later Stage VC | 13-Mar-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 24-Feb-2015 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 17-Oct-2014 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2013 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 18-Jun-2012 | $1.1M | $1.1M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Jan-2011 | Completed | Startup |
Eurofins Calixar Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A Preference | ||||||||
| Ordinary | ||||||||
| Class A Preference | 33,400 | $1.134983 | $28.37 | $28.37 | 1x | $28.37 | 28.17% |
Eurofins Calixar Comparisons
Industry
Financing
Details
Eurofins Calixar Competitors (3)
One of Eurofins Calixar’s 3 competitors is Novus Biologicals, a Formerly PE-Backed company based in Centennial, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novus Biologicals | Formerly PE-Backed | Centennial, CO | ||||
| Cusabio | Corporation | Houston, TX | ||||
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA |
Eurofins Calixar Signals
Eurofins Calixar Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ad-hoc Invest | Angel Group | Minority | ||
| Banque Populaire | Corporation | Minority | ||
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Crealys | Venture Capital | Minority | ||
| Grenoble Angels | Angel Group | Minority |
Eurofins Calixar FAQs
-
When was Eurofins Calixar founded?
Eurofins Calixar was founded in 2011.
-
Where is Eurofins Calixar headquartered?
Eurofins Calixar is headquartered in Lyon, France.
-
What is the size of Eurofins Calixar?
Eurofins Calixar has 13 total employees.
-
What industry is Eurofins Calixar in?
Eurofins Calixar’s primary industry is Drug Discovery.
-
Is Eurofins Calixar a private or public company?
Eurofins Calixar is a Private company.
-
What is Eurofins Calixar’s current revenue?
The current revenue for Eurofins Calixar is .
-
How much funding has Eurofins Calixar raised over time?
Eurofins Calixar has raised $4.99M.
-
Who are Eurofins Calixar’s investors?
Ad-hoc Invest, Banque Populaire, Bpifrance, Crealys, and Grenoble Angels are 5 of 12 investors who have invested in Eurofins Calixar.
-
Who are Eurofins Calixar’s competitors?
Novus Biologicals, Cusabio, and BioLegend are competitors of Eurofins Calixar.
-
When was Eurofins Calixar acquired?
Eurofins Calixar was acquired on 23-Apr-2023.
-
Who acquired Eurofins Calixar?
Eurofins Calixar was acquired by Eurofins Discovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process